News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,723 Results
Type
Article (40537)
Company Profile (297)
Press Release (664889)
Section
Business (207024)
Career Advice (2072)
Deals (35872)
Drug Delivery (99)
Drug Development (82353)
Employer Resources (176)
FDA (16230)
Job Trends (15160)
News (349978)
Policy (32831)
Tag
2024 BioCapital Digital (8)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (6)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (7)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (2566)
Accelerated approval (2)
Adcomms (20)
Allergies (80)
Alliances (50170)
ALS (85)
Alzheimer's disease (1374)
Antibody-drug conjugate (ADC) (115)
Approvals (16228)
Artificial intelligence (232)
Autoimmune disease (14)
Automation (14)
Bankruptcy (363)
Best Places to Work (11758)
BIOSECURE Act (20)
Biosimilars (104)
Biotechnology (212)
Bladder cancer (59)
Brain cancer (25)
Breast cancer (249)
Cancer (2010)
Cardiovascular disease (165)
Career advice (1725)
Career pathing (32)
CAR-T (140)
Cell therapy (402)
Cervical cancer (18)
Clinical research (66755)
Collaboration (776)
Compensation (455)
Complete response letters (21)
COVID-19 (2603)
CRISPR (35)
C-suite (216)
Cystic fibrosis (99)
Data (1965)
Decentralized trials (2)
Denatured (24)
Depression (42)
Diabetes (249)
Diagnostics (6349)
Digital health (17)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (111)
Drug pricing (99)
Drug shortages (25)
Duchenne muscular dystrophy (86)
Earnings (87238)
Editorial (37)
Employer branding (23)
Employer resources (150)
Events (114082)
Executive appointments (651)
FDA (17337)
Featured Employer (52)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (689)
Gene editing (98)
Generative AI (19)
Gene therapy (281)
GLP-1 (713)
Government (4421)
Grass and pollen (4)
Guidances (48)
Healthcare (18893)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (103)
Indications (27)
Infectious disease (2733)
Inflammatory bowel disease (133)
Inflation Reduction Act (9)
Influenza (46)
Intellectual property (87)
Interviews (328)
IPO (16722)
IRA (41)
Job creations (3837)
Job search strategy (1470)
Kidney cancer (9)
Labor market (34)
Layoffs (467)
Leadership (19)
Legal (7950)
Liver cancer (70)
Lung cancer (291)
Lymphoma (133)
Machine learning (4)
Management (58)
Manufacturing (270)
MASH (63)
Medical device (13336)
Medtech (13341)
Mergers & acquisitions (19623)
Metabolic disorders (644)
Multiple sclerosis (71)
NASH (16)
Neurodegenerative disease (78)
Neuropsychiatric disorders (26)
Neuroscience (1858)
NextGen: Class of 2025 (6572)
Non-profit (4496)
Northern California (2429)
Now hiring (38)
Obesity (347)
Opinion (219)
Ovarian cancer (73)
Pain (78)
Pancreatic cancer (76)
Parkinson's disease (134)
Partnered (20)
Patents (205)
Patient recruitment (94)
Peanut (46)
People (57938)
Pharmaceutical (76)
Pharmacy benefit managers (19)
Phase I (20829)
Phase II (29456)
Phase III (21838)
Pipeline (1031)
Podcasts (69)
Policy (117)
Postmarket research (2573)
Preclinical (8801)
Press Release (64)
Prostate cancer (95)
Psychedelics (31)
Radiopharmaceuticals (254)
Rare diseases (357)
Real estate (6025)
Recruiting (67)
Regulatory (22395)
Reports (46)
Research institute (2341)
Resumes & cover letters (354)
Rett syndrome (3)
RNA editing (4)
RSV (39)
Schizophrenia (66)
Series A (120)
Series B (78)
Service/supplier (11)
Sickle cell disease (50)
Southern California (2108)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (30)
Startups (3654)
State (2)
Stomach cancer (13)
Supply chain (61)
The Weekly (42)
United States (21352)
Vaccines (669)
Venture capitalists (38)
Webinars (12)
Weight loss (233)
Women's health (36)
Worklife (18)
Date
Today (233)
Last 7 days (719)
Last 30 days (2790)
Last 365 days (34085)
2025 (8088)
2024 (35730)
2023 (40661)
2022 (51785)
2021 (56341)
2020 (54536)
2019 (46982)
2018 (35391)
2017 (32636)
2016 (32065)
2015 (38116)
2014 (32009)
2013 (26901)
2012 (29018)
2011 (29672)
2010 (27710)
Location
Africa (741)
Alabama (54)
Alaska (7)
Arizona (226)
Arkansas (14)
Asia (39009)
Australia (6309)
California (5552)
Canada (1874)
China (491)
Colorado (248)
Connecticut (259)
Delaware (128)
Europe (84103)
Florida (829)
Georgia (192)
Idaho (57)
Illinois (498)
India (23)
Indiana (293)
Iowa (9)
Japan (142)
Kansas (100)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (841)
Massachusetts (4209)
Michigan (209)
Minnesota (371)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (25)
Nevada (56)
New Hampshire (62)
New Jersey (1592)
New Mexico (29)
New York (1593)
North Carolina (970)
North Dakota (7)
Northern California (2429)
Ohio (191)
Oklahoma (14)
Oregon (34)
Pennsylvania (1258)
Puerto Rico (10)
Rhode Island (26)
South America (1120)
South Carolina (18)
South Dakota (1)
Southern California (2108)
Tennessee (92)
Texas (832)
Utah (165)
Virginia (130)
Washington D.C. (58)
Washington State (521)
West Virginia (3)
Wisconsin (49)
705,723 Results for "sunshine biopharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market
March 10, 2025
·
3 min read
Press Releases
Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada
March 25, 2025
·
3 min read
Press Releases
Sunshine Biopharma Announces the Appointment of New Chief Commercial Officer
January 15, 2025
·
4 min read
Business
Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%
Sunshine Biopharma, Inc. today announced that it has filed its 2024 first quarter report with the Securities and Exchange Commission.
May 21, 2024
·
3 min read
Press Releases
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus
December 9, 2024
·
4 min read
Deals
Sunshine Biopharma Announces Reverse Stock Split
Sunshine Biopharma, Inc. announced today a one for one hundred reverse split of its common stock, effective at market open on April 17, 2024.
April 12, 2024
·
2 min read
Press Releases
Sunshine Biopharma Launches a New Generic Prescription Drug
November 22, 2024
·
3 min read
Press Releases
Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT
January 21, 2025
·
3 min read
Press Releases
Sunshine Biopharma Launches a New Generic Prescription Drug - December 4, 2024
December 5, 2024
·
3 min read
Pharm Country
Sunshine Biopharma, Inc. Announces Closing of $10.0 Million Underwritten Public Offering
Sunshine Biopharma, Inc. announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company of approximately $10.0 million, before deducting underwriting discounts and other estimated expenses payable by the Company.
February 15, 2024
·
4 min read
1 of 70,573
Next
